Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 3
2009 1
2010 1
2012 4
2013 2
2014 1
2015 6
2016 5
2017 2
2018 3
2019 5
2020 4
2021 6
2022 10
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial.
Johnstone J, Meade M, Lauzier F, Marshall J, Duan E, Dionne J, Arabi YM, Heels-Ansdell D, Thabane L, Lamarche D, Surette M, Zytaruk N, Mehta S, Dodek P, McIntyre L, English S, Rochwerg B, Karachi T, Henderson W, Wood G, Ovakim D, Herridge M, Granton J, Wilcox ME, Goffi A, Stelfox HT, Niven D, Muscedere J, Lamontagne F, D'Aragon F, St-Arnaud C, Ball I, Nagpal D, Girard M, Aslanian P, Charbonney E, Williamson D, Sligl W, Friedrich J, Adhikari NK, Marquis F, Archambault P, Khwaja K, Kristof A, Kutsogiannis J, Zarychanski R, Paunovic B, Reeve B, Lellouche F, Hosek P, Tsang J, Binnie A, Trop S, Loubani O, Hall R, Cirone R, Reynolds S, Lysecki P, Golan E, Cartin-Ceba R, Taylor R, Cook D; Prevention of Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT) Investigators and the Canadian Critical Care Trials Group. Johnstone J, et al. JAMA. 2021 Sep 21;326(11):1024-1033. doi: 10.1001/jama.2021.13355. JAMA. 2021. PMID: 34546300 Free PMC article. Clinical Trial.
IMPORTANCE: Growing interest in microbial dysbiosis during critical illness has raised questions about the therapeutic potential of microbiome modification with probiotics. Prior randomized trials in this population suggest that probiotics reduce infection, particul …
IMPORTANCE: Growing interest in microbial dysbiosis during critical illness has raised questions about the therapeutic potential of microbio …
Non-Pharmacological Interventions to Prevent Ventilator-Associated Pneumonia: A Literature Review.
Coppadoro A, Bellani G, Foti G. Coppadoro A, et al. Respir Care. 2019 Dec;64(12):1586-1595. doi: 10.4187/respcare.07127. Epub 2019 Sep 24. Respir Care. 2019. PMID: 31551284 Free article. Review.
Ventilator-associated pneumonia (VAP) is a well-known complication of invasive mechanical ventilation in critically ill patients. ...Other interventions target a patient's position in the bed to reduce aspiration of digestive content in the airw …
Ventilator-associated pneumonia (VAP) is a well-known complication of invasive mechanical ventilation in …
Prevention of Intensive Care Unit-Acquired Pneumonia.
Klompas M. Klompas M. Semin Respir Crit Care Med. 2019 Aug;40(4):548-557. doi: 10.1055/s-0039-1695783. Epub 2019 Oct 4. Semin Respir Crit Care Med. 2019. PMID: 31585480 Review.
Intensive care unit (ICU) acquired pneumonia is one of the most common and morbid health care-associated infections. ...Oral care with chlorhexidine may increase mortality risk and stress ulcer prophylaxis may facilitate pneumonia. Early data on probiotics …
Intensive care unit (ICU) acquired pneumonia is one of the most common and morbid health care-associated infections. ...Oral c …
Drug Prevention and Control of Ventilator-Associated Pneumonia.
Xie X, Lyu J, Hussain T, Li M. Xie X, et al. Front Pharmacol. 2019 Mar 28;10:298. doi: 10.3389/fphar.2019.00298. eCollection 2019. Front Pharmacol. 2019. PMID: 31001116 Free PMC article. Review.
Ventilator-associated pneumonia (VAP) is one of the most prevalent and serious complications of mechanical ventilation, which is considered a common nosocomial infection in critically ill patients. ...Furthermore, clinical management of VAP depe …
Ventilator-associated pneumonia (VAP) is one of the most prevalent and serious complications of mechanical ve …
Probiotics for preventing ventilator-associated pneumonia.
Bo L, Li J, Tao T, Bai Y, Ye X, Hotchkiss RS, Kollef MH, Crooks NH, Deng X. Bo L, et al. Cochrane Database Syst Rev. 2014 Oct 25;10(10):CD009066. doi: 10.1002/14651858.CD009066.pub2. Cochrane Database Syst Rev. 2014. PMID: 25344083 Free PMC article. Review.
BACKGROUND: Ventilator-associated pneumonia (VAP) is common in intensive care units (ICUs). ...However, the aggregated results were uncertain for ICU mortality (OR 0.84, 95% CI 0.58 to 1.22 very low quality evidence), in-hospital mortality (OR 0.78, 95% CI 0. …
BACKGROUND: Ventilator-associated pneumonia (VAP) is common in intensive care units (ICUs). ...However, the aggregated …
Probiotics for the Prevention of Ventilator-Associated Pneumonia: An Updated Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Cheema HA, Shahid A, Ayyan M, Mustafa B, Zahid A, Fatima M, Ehsan M, Athar F, Duric N, Szakmany T. Cheema HA, et al. Nutrients. 2022 Apr 12;14(8):1600. doi: 10.3390/nu14081600. Nutrients. 2022. PMID: 35458162 Free PMC article. Review.
BACKGROUND: Presently, there is conflicting evidence regarding the efficacy of probiotics in the prevention of ventilator-associated pneumonia (VAP). This meta-analysis was conducted to update current clinical evidence and evaluate the efficacy and saf …
BACKGROUND: Presently, there is conflicting evidence regarding the efficacy of probiotics in the prevention of ventilator-a …
The function of probiotics on the treatment of ventilator-associated pneumonia (VAP): facts and gaps.
Karacaer F, Hamed I, Özogul F, Glew RH, Özcengiz D. Karacaer F, et al. J Med Microbiol. 2017 Sep;66(9):1275-1285. doi: 10.1099/jmm.0.000579. Epub 2017 Aug 31. J Med Microbiol. 2017. PMID: 28855004 Review.
Their therapeutic effects are due to the production of a variety of antimicrobial compounds, such as short-chain fatty acids, organic acids (such as lactic, acetic, formic, propionic and butyric acids), ethanol, hydrogen peroxide and bacteriocins. Ventilator-associated …
Their therapeutic effects are due to the production of a variety of antimicrobial compounds, such as short-chain fatty acids, organic acids …
Lung Microbiota and Ventilator-Associated Pneumonia in the Neonatal Period.
García-Muñoz Rodrigo F, Urquía Martí L, Siguero Onrubia M, Borges Luján M, Galán Henríquez G, Reyes Suárez D. García-Muñoz Rodrigo F, et al. Pathogens. 2024 Mar 1;13(3):220. doi: 10.3390/pathogens13030220. Pathogens. 2024. PMID: 38535563 Free PMC article. Review.
Although advances in neonatal intensive care units have significantly improved the survival rate of preterm infants, the diagnosis and treatment of ventilator-associated pneumonia has not progressed in recent decades. Avoiding dysbiosis caused by inappropriat …
Although advances in neonatal intensive care units have significantly improved the survival rate of preterm infants, the diagnosis and treat …
Do probiotics help prevent ventilator-associated pneumonia in critically ill patients? A systematic review with meta-analysis.
Zhao J, Li LQ, Chen CY, Zhang GS, Cui W, Tian BP. Zhao J, et al. ERJ Open Res. 2021 Jan 25;7(1):00302-2020. doi: 10.1183/23120541.00302-2020. eCollection 2021 Jan. ERJ Open Res. 2021. PMID: 33532460 Free PMC article. Review.
BACKGROUND: Probiotic treatments might contribute to the prevention of ventilator-associated pneumonia (VAP). ...The characteristics of the studies were extracted, including study design, definition of VAP, probiotics intervention, category of i …
BACKGROUND: Probiotic treatments might contribute to the prevention of ventilator-associated pneumonia (VAP). .. …
53 results